JPRN-UMIN000006770
Completed
未知
sefulness of salmeterol/fluticasone combination (SFC) therapy in preschool children with uncontrolled asthma treated with inhaled corticosteroid. - Usefulness of salmeterol/fluticasone combination (SFC) therapy in preschool children with uncontrolled asthma treated with inhaled corticosteroid.
ConditionsPreschool children with asthma
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Preschool children with asthma
- Sponsor
- Dokkyo Medical University
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients already treated with SFC. 2\)Use inhaled, patch, and oral bronchodilator as long\-term management (controller). 3\)Patients have hypersensitivity to salmeterol or fluticasone propionate, or suspected patient. 4\)The patients who are inappropriate considered by physician.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Treatment Of Partial Reversible Chronic Obstructive Pulmonary DiseasePulmonary Disease, Chronic ObstructiveNCT00549146GlaxoSmithKline290
Active, not recruiting
Not Applicable
Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide™ Accuhaler™ in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group studyEUCTR2007-005620-32-LTHEXAL AG472
Active, not recruiting
Phase 1
Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide™ Accuhaler™ in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group studyEUCTR2007-005620-32-PLHEXAL AG472
Active, not recruiting
Not Applicable
Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide™ Accuhaler™ in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group studymoderate-to-severe persistent asthmaMedDRA version: 9.1Level: LLTClassification code 10003555Term: Asthma bronchialEUCTR2007-005620-32-HUHEXAL AG472
Terminated
Phase 4
Salmeterol/Fluticasone 50/500 mcg Inhalation Powder Via Capsair vs Seretide Diskus 500 mcg Inhalation Powder in Patients With COPDCOPDNCT03363503Neutec Ar-Ge San ve Tic A.Ş64